u-PA expression in benign, borderline and malignant ovarian tumors

被引:0
|
作者
Kiziridou, AD
Toliou, T
Stefanou, D
Agnantis, N
机构
[1] Theagen Anticanc Inst thessaloniki, Dept Pathol, Thessaloniki 54007, Greece
[2] Univ Ioannina, Sch Med, Dept Pathol, Ioannina 45100, Greece
关键词
plasminogen activator; ovarian carcinoma; borderline tumors; immunohistochemistry;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The malignant potential of solid tumors is related to their ability to invade adjacent tissue and to metastasize. The plasminogen activation system is one of the critical factors in tumor progression since it is involved in tumor invasion and metastasis. This study was performed to examine the expression of u-PA in benign, borderline and malignant tumors of the ovary by immunohistochemical evaluation on formalin-fixed, paraffin-embedded specimens applying monoclonal antibody 3689 directed to the b-chain of u-PA. Normal epithelial cells of the ovary (n =5) showed no staining of u-PA but some stromal cells were slightly stained. Invasive carcinomas (n=16) and borderline tumors (n = 15) showed a moderate to strong diffuse cytoplasmic staining. Benign tumors (n=20) showed a variety of staining. The observation of randomly positive u-PA stromal cells is noteworthy. The percentage of u-PA-positive tumors was higher in carcinomas than in other tumors. There was no con-elation with other known risk factors of malignancy such as differentiation, stage or type of tumor, In conclusion there are noticeable differences in u-PA expression among ovarian tumors and u-PA increase in ovarian tumors can be attributed to an increased diffuse cytoplasmic content in the neoplastic epithelial cells.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 50 条
  • [21] High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
    Borgfeldt, C
    Casslén, B
    Liu, CL
    Hansson, S
    Lecander, I
    Åstedt, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (06) : 588 - 595
  • [22] Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors
    Steffensen, Karina Dahl
    Waldstrom, Marianne
    Olsen, Dorte Aalund
    Corydon, Thomas
    Lorentzen, Karen Axelgaard
    Knudsen, Hans Jorgen
    Jeppesen, Ulla
    Brandslund, Ivan
    Jakobsen, Anders
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (11) : 3278 - 3282
  • [23] Clinical and ultrasound features of benign, borderline, and malignant invasive mucinous ovarian tumors
    Pascual, A.
    Guerriero, S.
    Rams, N.
    Juez, L.
    Ajossa, S.
    Graupera, B.
    Hereter, L.
    Cappai, A.
    Pero, M.
    Perniciano, M.
    Errasti, T.
    Parra, J.
    Solis, M.
    Alcazar, J. L.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (03) : 382 - 386
  • [24] Apoptosis in ovarian tumors (benign, borderline, malignant) and correlation with BCL-2 and P53 expression
    Dawamneh, MF
    Pau, J
    Attal, H
    Visscher, D
    Bedrossian, C
    [J]. LABORATORY INVESTIGATION, 1997, 76 (01) : 566 - 566
  • [25] OVARIAN TUMORS OF LOW MALIGNANT POTENTIAL (BORDERLINE OVARIAN TUMORS)
    Luchian, Alina-Mihaela
    Pricop, M.
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2011, 115 (02): : 438 - 445
  • [26] u-PA expression in normal myeloid differentiation and leukaemia
    Chee, YL
    Berry, S
    Greaves, M
    Bennett, B
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 48 - 48
  • [27] Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors
    Xiao, Fuxia
    Zhang, Lin
    Yang, Sihua
    Peng, Kun
    Hua, Ting
    Tang, Guangyu
    [J]. JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [28] Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors
    Fuxia Xiao
    Lin Zhang
    Sihua Yang
    Kun Peng
    Ting Hua
    Guangyu Tang
    [J]. Journal of Ovarian Research, 15
  • [29] Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelial tumors
    Kalir, T
    Wang, BY
    Goldfischer, M
    Reder, E
    Demopoulos, R
    Cohen, CJ
    Burstein, DE
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 200A - 200A
  • [30] TUMOR-MARKERS IN BENIGN, BORDERLINE AND MALIGNANT OVARIAN-TUMORS OF EPITHELIAL GROWTH
    DIETEL, M
    HOLZEL, F
    SIMON, W
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 105 (02) : A39 - A39